Leisure Products

CHINAHEALTHWISE

CHINAHEALTHWISE released FY2025 Q3 earnings on March 27, 2026 (BJT) with actual revenue of HKD 24.25 M and EPS of HKD -0.0026

CHINAHEALTHWISE released FY2025 9 Months earnings on March 27 (BJT), actual revenue HKD 75.31 M, actual EPS HKD -0.0007

CHINAHEALTHWISE released FY2025 earnings on March 27 During-Market (BJT), actual revenue HKD 99.56 M, actual EPS HKD -0.0033

CHINAHEALTHWISE released FY2025 Q4 earnings on March 27 During-Market (BJT), actual revenue HKD 24.25 M, actual EPS HKD -0.0026

CHINAHEALTHWISE FY2025 Earnings Release on March 27 During-Market BJT

CHINAHEALTHWISE released FY2025 Q1 earnings on August 27 (BJT), actual revenue HKD 25.53 M, actual EPS HKD 0.0009

CHINAHEALTHWISE released FY2025 Semi-Annual Earnings on August 27 During-Market BJT, actual revenue HKD 51.06 M, actual EPS HKD 0.0018

CHINAHEALTHWISE released FY2025 Q2 earnings on August 27 During-Market (BJT), actual revenue HKD 25.53 M, actual EPS HKD 0.0009

CHINAHEALTHWISE to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

China Intelligent Health Releases 2024 Annual Results, Revenue Decreases by 22.38%, Shareholder Loss Narrows by 70.06%

CHINAHEALTHWISE released FY2024 9 Months Earnings on March 31 (BJT), with actual revenue of 87.25 M HKD and EPS of -0.0447 HKD

CHINAHEALTHWISE released FY2024 Q3 earnings on March 31 (BJT), actual revenue 26.32 M HKD, actual EPS -0.0075 HKD

CHINAHEALTHWISE released FY2024 annual earnings on March 31 After-Market (BJT), actual revenue 113.58 M HKD, actual EPS -0.0522 HKD

CHINAHEALTHWISE released FY2024 Q4 earnings on March 31 After-Market (BJT), actual revenue 26.32 M HKD, actual EPS -0.0075 HKD

China Smart Health Expects Significant Reduction in Losses to HKD 38 Million to 42 Million for FY 2024

Miaoying Technology Announces ESG Rating Results for China Smart Health in 2024, Achieving BBB Rating

CHINAHEALTHWISE to Release FY2024 Earnings on March 25, 2025, After-Market BJT

China Smart Health plans to issue bonds to Heng Tai Finance Limited

China Smart Health (00348) Announcement: Huang Dequan resigned as independent non-executive director, Zeng Zhanpeng appointed

China Smart Health (00348) releases 2023 annual performance

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

00348

00376

CHINAHEALTHWISE announced that on April 10th, it sold a total of 500,000 shares of YUNFENG FIN for approximately HKD 1.56 million, equivalent to an average price of HKD 3.13 per share. It is estimated that the sale will result in a pre-tax loss of approximately HKD 16,000. After the completion, the company still holds 2.684 million shares of YUNFENG FIN

AASTOCKS

YUNFENG FIN

CHINAHEALTHWISE reduced its holdings in YUNFENG FIN by 500,000 shares, realizing 1.56 million

CHINAHEALTHWISE announced its full-year results for the year ended December last year, with a revenue of HKD 99.564 million, a year-on-year decrease of 12.3%. The loss narrowed to HKD 2.606 million, compared to a loss of HKD 40.281 million in the same period last year; the loss per share was HKD 0.34. No dividend was declared

"Performance" CHINAHEALTHWISE's annual loss narrowed to 2.606 million yuan

China Healthwise Extends Unsecured HK$9 Million Loan and Fixes Interest at 10%

Tip Ranks

China Healthwise Extends Unsecured HK$9 Million Loan and Fixes Interest at 10%

01069

000090

CN HEALTH TECH announced its interim results for the six months ending December 2025, with revenue of 34.39 million RMB, an increase of 10.5% year-on-year. It recorded a net profit of 5.25 million RMB, a growth of 5.5%, with earnings per share of 5.25 cents. No dividend was declared

CN HEALTH TECH

TAGEN GROUP

"Performance" CN HEALTH TECH's interim net profit is RMB 5.25 million, an increase of 5.5%, no dividend declared

According to the Zhitong Finance APP, CHINAHEALTHWISE announced that Mr. Yang Qiangsheng has resigned as the company's executive director to devote more time to his personal affairs, effective October 31, 2025. On the same day, Mr. Feng Weizheng has been appointed as the company's independent non-executive director, a member of the audit committee, and a member of the nomination committee

Zhitong

CHINAHEALTHWISE appoints Feng Weizheng as an independent non-executive director

According to the Zhitong Finance APP, CHINAHEALTHWISE announced its interim results for the six months ended June 30, 2025, with group revenue of HKD 51.06 million, a year-on-year decrease of 16.2%; shareholders' profit attributable to the company was HKD 1.418 million, turning from loss to profit year-on-year; earnings per share were HKD 0.0018

CHINAHEALTHWISE released its interim results, with a profit attributable to shareholders of HKD 1.418 million, turning a profit compared to the same period last year

CHINAHEALTHWISE expects its interim profit attributable to shareholders for the period ending June 30, 2025, to be approximately HKD 1 million to HKD 2 million, a significant improvement compared to a loss of HKD 29 million in the same period of 2024. The main reasons for the turnaround in profit include: a reversal of impairment on receivables of approximately HKD 3 million, a reduction in administrative expenses to approximately HKD 8 million, and unrealized fair value gains on financial assets of approximately HKD 12 million

CHINAHEALTHWISE issues a profit warning, expecting mid-term shareholder profit attributable to shareholders to be approximately HKD 100,000 to 2 million

According to the Zhitong Finance APP, CHINAHEALTHWISE announced that Mr. Lian Weixiong has resigned as the company's independent non-executive director and as a member of the audit committee, nomination committee, and remuneration committee, effective August 1, 2025, due to the need for more time to handle other business commitments

CHINAHEALTHWISE: Lian Weixiong resigns as independent non-executive director

According to the Zhitong Finance APP, CHINAHEALTHWISE announced that Ms. Lao Mingyun, the company's executive director, has been appointed as a member of the company's nomination committee, effective from June 27, 2025

CHINAHEALTHWISE appoints Lao Mingyun as a member of the nomination committee

According to the Zhitong Finance APP, CHINAHEALTHWISE released its full-year results for the year ending December 31, 2024, with revenue of HKD 114 million, a year-on-year decrease of 22.38%; the loss attributable to shareholders was HKD 40.281 million, a year-on-year narrowing of 70.06%; the basic loss per share was HKD 0.0523

CHINAHEALTHWISE released its annual performance, with a loss attributable to shareholders of HKD 40.281 million, a year-on-year narrowing of 70.06%

CHINAHEALTHWISE(00348.HK)

CHINAHEALTHWISE reduced its holdings in YUNFENG FIN by 500,000 shares, realizing 1.56 million

"Performance" CHINAHEALTHWISE's annual loss narrowed to 2.606 million yuan

China Healthwise Extends Unsecured HK$9 Million Loan and Fixes Interest at 10%

"Performance" CN HEALTH TECH's interim net profit is RMB 5.25 million, an increase of 5.5%, no dividend declared

CHINAHEALTHWISE appoints Feng Weizheng as an independent non-executive director

CHINAHEALTHWISE released its interim results, with a profit attributable to shareholders of HKD 1.418 million, turning a profit compared to the same period last year

CHINAHEALTHWISE issues a profit warning, expecting mid-term shareholder profit attributable to shareholders to be approximately HKD 100,000 to 2 million

CHINAHEALTHWISE: Lian Weixiong resigns as independent non-executive director

CHINAHEALTHWISE appoints Lao Mingyun as a member of the nomination committee

CHINAHEALTHWISE released its annual performance, with a loss attributable to shareholders of HKD 40.281 million, a year-on-year narrowing of 70.06%